Next Article in Journal
Target Profile Prediction and Practical Evaluation of a Biginelli-Type Dihydropyrimidine Compound Library
Next Article in Special Issue
Coupling Aptamers to Short Interfering RNAs as Therapeutics
Previous Article in Journal
In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions
Previous Article in Special Issue
Aptamer-Gated Nanoparticles for Smart Drug Delivery
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2011, 4(9), 1216-1235;

Methods To Identify Aptamers against Cell Surface Biomarkers

CEA, DSV, I²BM, Service Hospitalier Frédéric Joliot (SHFJ), 4 place du général Leclerc, 91401 Orsay, France
INSERM U1023, 4 place du général Leclerc, 91401 Orsay, France
Université Paris Sud, 4 place du général Leclerc, 91401 Orsay, France
Department of Molecular Biology, Aarhus University, Gustav Wieds Vej 10C, 8000 Aarhus C, Denmark
Author to whom correspondence should be addressed.
Received: 1 August 2011 / Revised: 2 September 2011 / Accepted: 9 September 2011 / Published: 20 September 2011
(This article belongs to the Special Issue Aptamer-Based Therapeutics)
PDF [805 KB, uploaded 21 September 2011]


Aptamers are nucleic acid-based ligands identified through a process of molecular evolution named SELEX (Systematic Evolution of Ligands by Exponential enrichment). During the last 10-15 years, numerous aptamers have been developed specifically against targets present on or associated with the surface of human cells or infectious pathogens such as viruses, bacteria, fungi or parasites. Several of the aptamers have been described as potent probes, rivalling antibodies, for use in flow cytometry or microscopy. Some have also been used as drugs by inhibiting or activating functions of their targets in a manner similar to neutralizing or agonistic antibodies. Additionally, it is straightforward to conjugate aptamers to other agents without losing their affinity and they have successfully been used in vitro and in vivo to deliver drugs, siRNA, nanoparticles or contrast agents to target cells. Hence, aptamers identified against cell surface biomarkers represent a promising class of ligands. This review presents the different strategies of SELEX that have been developed to identify aptamers for cell surface-associated proteins as well as some of the methods that are used to study their binding on living cells. View Full-Text
Keywords: aptamers; SELEX; cell surface biomarkers; methods aptamers; SELEX; cell surface biomarkers; methods
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Cibiel, A.; Dupont, D.M.; Ducongé, F. Methods To Identify Aptamers against Cell Surface Biomarkers. Pharmaceuticals 2011, 4, 1216-1235.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top